Filing Details

Accession Number:
0001209191-20-032445
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-05-27 19:54:51
Reporting Period:
2020-05-22
Accepted Time:
2020-05-27 19:54:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
353569 Quidel Corp QDEL In Vitro & In Vivo Diagnostic Substances (2835) 942573850
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1609320 Werner Kroll 9975 Summers Ridge Road
San Diego CA 92121
Svp, R&D No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-05-22 17,596 $23.41 22,195 No 4 M Direct
Common Stock Acquisiton 2020-05-22 35,192 $15.40 57,387 No 4 M Direct
Common Stock Acquisiton 2020-05-22 10,758 $21.08 68,145 No 4 M Direct
Common Stock Acquisiton 2020-05-22 4,606 $46.41 72,751 No 4 M Direct
Common Stock Disposition 2020-05-22 68,152 $174.44 4,599 No 4 S Direct
Common Stock Acquisiton 2020-05-27 4,376 $0.00 8,975 No 4 M Direct
Common Stock Disposition 2020-05-27 2,304 $0.00 6,671 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 F Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Options Disposition 2020-05-22 17,596 $0.00 17,596 $23.41
Common Stock Non-Qualified Stock Options Disposition 2020-05-22 35,192 $0.00 35,192 $15.40
Common Stock Non-Qualified Stock Options Disposition 2020-05-22 10,758 $0.00 10,758 $21.08
Common Stock Non-Qualified Stock Options Disposition 2020-05-22 4,606 $0.00 4,606 $46.41
Common Stock Restricted Stock Units Disposition 2020-05-27 4,376 $0.00 4,376 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2025-02-05 No 4 M Direct
0 2026-02-10 No 4 M Direct
3,585 2027-02-15 No 4 M Direct
4,606 2028-01-16 No 4 M Direct
8,752 No 4 M Direct
Footnotes
  1. The amount of securities beneficially owned following this transaction include an additional 272 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan.
  2. The weighted average sale price for these transactions was $174.4358 per share, with a range of $171.69 to $180.50. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
  3. Reflects release of restricted stock units that were previously reported on Form 4.
  4. The disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon vesting of restricted stock units.
  5. 17,596 shares vested on 02/05/2017; 8,798 shares vested on 02/05/2018; and 8,798 shares vested on 02/05/2019.
  6. 17,596 shares vested on 02/10/2018; 8,798 shares vested on 02/10/2019; and 8,798 shares vested on 02/10/2020.
  7. 7,172 shares vested on 02/15/2019; 3,586 shares vested on 02/15/2020; and 3,585 shares will vest on 02/15/2021.
  8. 4,606 shares vested on 01/16/2020; 2,303 shares will vest on 01/16/2021; and 2,303 shares will vest on 01/16/2022.
  9. Restricted stock units convert into common stock on a one-for-one basis.
  10. On 05/27/2014, the Reporting Person was granted 17,505 restricted stock units vesting as follows: 4,377 shares vested on 05/27/2019; 4,376 shares vested on 05/27/2020; 4,376 shares will vest on 05/27/2021; and 4,376 shares will vest on 05/27/2022.